Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q3 2020 · 10-Q
Revenue$0.00$0.00— vs Q3 2019 Net Income-$999.28K-$999.28KN/M vs Q3 2019 EPS Diluted-$0.01-$0.01no prior Q3 2019 on file The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
Operating Cash Flowderived-$26,117N/M ended Apr 30, 2020 · filed Jun 4, 2020 · 35 d after period end